Haemonetics
295 hedge funds and large institutions have $4.36B invested in Haemonetics in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 91 increasing their positions, 118 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
295
Holders Change
-1
Holders Change %
-0.34%
% of All Funds
4.32%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
37
Increased
91
Reduced
118
Closed
36
Calls
$16M
Puts
$4.78M
Net Calls
+$11.2M
Net Calls Change
-$4.49M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$32.1M |
| 2 |
BlackRock
New York
|
+$22.1M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$21M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$13M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$9.01M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$15.8M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
-$12.9M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$12.8M |
| 4 |
CCM
Cinctive Capital Management
New York
|
-$12.5M |
| 5 |
LCP
LGT Capital Partners
Pfaeffikon,
Switzerland
|
-$10M |
